It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The Ca2+ modulated pulsatile glucagon and insulin secretions by pancreatic α and β cells play a crucial role in glucose homeostasis. However, how α and β cells coordinate to produce various Ca2+ oscillation patterns is still elusive. Using a microfluidic device and transgenic mice, we recorded Ca2+ signals from islet α and β cells, and observed heterogeneous Ca2+ oscillation patterns intrinsic to each islet. After a brief period of glucose stimulation, α and β cells’ oscillations were globally phase-locked. While the activation of α cells displayed a fixed time delay of ~20 s to that of β cells, β cells activated with a tunable period. Moreover, islet α cell number correlated with oscillation frequency. We built a mathematical model of islet Ca2+ oscillation incorporating paracrine interactions, which quantitatively agreed with the experimental data. Our study highlights the importance of cell-cell interaction in generating stable but tunable islet oscillation patterns.
The Ca2+ modulated pulsatile glucagon and insulin secretions by pancreatic α and β cells are critical in glucose homeostasis. Here the authors show that the Ca2+ oscillations of α and β cells are phase-locked, and that the oscillation pattern is tuned by paracrine interactions between α and β cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Peking University, Center for Quantitative Biology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking University, Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
2 Peking University, Center for Quantitative Biology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking University, Institute of Molecular Medicine, School of Future Technology, National Biomedical Imaging Center, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
3 Peking University, Institute of Molecular Medicine, School of Future Technology, National Biomedical Imaging Center, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
4 Peking University, Center for Quantitative Biology, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
5 Peking University, Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
6 Peking University, Yuanpei College, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)
7 University of Copenhagen, Niels Bohr Institute, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X)
8 Peking University, Peking-Tsinghua Center for Life Sciences, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319); Peking University, Institute of Molecular Medicine, School of Future Technology, National Biomedical Imaging Center, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319)